150 related articles for article (PubMed ID: 26211755)
1. Computer-aided design of T-cell epitope-based vaccines: addressing population coverage.
Oyarzun P; Kobe B
Int J Immunogenet; 2015 Oct; 42(5):313-21. PubMed ID: 26211755
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T cell epitope discovery and rational vaccine design.
Rosa DS; Ribeiro SP; Cunha-Neto E
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):121-30. PubMed ID: 20155490
[TBL] [Abstract][Full Text] [Related]
3. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.
Oyarzún P; Ellis JJ; Bodén M; Kobe B
BMC Bioinformatics; 2013 Feb; 14():52. PubMed ID: 23409948
[TBL] [Abstract][Full Text] [Related]
4. Predicting population coverage of T-cell epitope-based diagnostics and vaccines.
Bui HH; Sidney J; Dinh K; Southwood S; Newman MJ; Sette A
BMC Bioinformatics; 2006 Mar; 7():153. PubMed ID: 16545123
[TBL] [Abstract][Full Text] [Related]
5. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of peptide selection approaches for epitope-based vaccine design.
Schubert B; Lund O; Nielsen M
Tissue Antigens; 2013 Oct; 82(4):243-51. PubMed ID: 24461003
[TBL] [Abstract][Full Text] [Related]
7. Epitope prediction and identification- adaptive T cell responses in humans.
Sidney J; Peters B; Sette A
Semin Immunol; 2020 Aug; 50():101418. PubMed ID: 33131981
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex linked databases and prediction tools for designing vaccines.
Singh SP; Mishra BN
Hum Immunol; 2016 Mar; 77(3):295-306. PubMed ID: 26585361
[TBL] [Abstract][Full Text] [Related]
9. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.
Tine JA; Firat H; Payne A; Russo G; Davis SW; Tartaglia J; Lemonnier FA; Demoyen PL; Moingeon P
Vaccine; 2005 Jan; 23(8):1085-91. PubMed ID: 15620483
[TBL] [Abstract][Full Text] [Related]
10. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
11. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
[TBL] [Abstract][Full Text] [Related]
12. Towards in silico design of epitope-based vaccines.
Toussaint NC; Kohlbacher O
Expert Opin Drug Discov; 2009 Oct; 4(10):1047-60. PubMed ID: 23480396
[TBL] [Abstract][Full Text] [Related]
13. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.
De Groot AS; Moise L; Terry F; Gutierrez AH; Hindocha P; Richard G; Hoft DF; Ross TM; Noe AR; Takahashi Y; Kotraiah V; Silk SE; Nielsen CM; Minassian AM; Ashfield R; Ardito M; Draper SJ; Martin WD
Front Immunol; 2020; 11():442. PubMed ID: 32318055
[TBL] [Abstract][Full Text] [Related]
14. Immunoinformatic Identification of Potential Epitopes.
Desai P; Tarwadi D; Pandya B; Yagnik B
Methods Mol Biol; 2020; 2131():265-275. PubMed ID: 32162260
[TBL] [Abstract][Full Text] [Related]
15. In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B--a clue for vaccine development.
Gupta SK; Smita S; Sarangi AN; Srivastava M; Akhoon BA; Rahman Q; Gupta SK
Vaccine; 2010 Oct; 28(43):7092-7. PubMed ID: 20716448
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space.
Ogishi M; Yotsuyanagi H
Front Immunol; 2019; 10():827. PubMed ID: 31057550
[TBL] [Abstract][Full Text] [Related]
17. New tools, new approaches and new ideas for vaccine development.
De Groot AS; Moise L
Expert Rev Vaccines; 2007 Apr; 6(2):125-7. PubMed ID: 17408360
[No Abstract] [Full Text] [Related]
18. Proteome-wide B and T cell epitope repertoires in outer membrane proteins of Mycobacterium avium subsp. paratuberculosis have vaccine and diagnostic relevance: a holistic approach.
Rana A; Rub A; Akhter Y
J Mol Recognit; 2015 Aug; 28(8):506-20. PubMed ID: 25727233
[TBL] [Abstract][Full Text] [Related]
19. Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design.
Halling-Brown M; Shaban R; Frampton D; Sansom CE; Davies M; Flower D; Duffield M; Titball RW; Brusic V; Moss DS
Mol Immunol; 2009 Aug; 46(13):2699-705. PubMed ID: 19560824
[TBL] [Abstract][Full Text] [Related]
20. T cell epitope identification for bovine vaccines: an epitope mapping method for BoLA A-11.
De Groot AS; Nene V; Hegde NR; Srikumaran S; Rayner J; Martin W
Int J Parasitol; 2003 May; 33(5-6):641-53. PubMed ID: 12782061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
